A Randomised, Double-blind, Placebo-controlled, Parallel-group Trial to Assess Clinical Efficacy and Safety of NNC0114-0006 in Subjects With Active Crohn's Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to assess clinical efficacy and safety of NNC0114-0006 in subjects with active Crohn\'s disease.
Epistemonikos ID: 44767c1aa8dfb761e4d63ab12398f6c0af8e405a
First added on: May 11, 2024